5SJ-74868-73872 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-26
Dose 1 — Pfizer-BioNTech
2021-05-10
Dose 2 — Pfizer-BioNTech
2021-08-01
Registered in v-safe
2021-08-09
Survey response — 3 months, dose 2
MedDRA: Headache, Muscle spasms, Nasal congestion, Nausea — Feeling: Fair · Be unable to work or attend school

Free text: Stuffy nose, cramps, headaches, nausea

MedDRA releases: 2021-09,2024-11 · check-in free text available
2022-05-10
Survey response — 12 months, dose 2
MedDRA: Delivery, Dyspnoea, Influenza, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Gave birth. Frequent cold/flu symptoms and hard time breathing

MedDRA releases: 2024-11 · check-in free text available
2022-05-10
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-05-11
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-26	Pfizer-BioNTech	No
2	2021-05-10	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-05-10	Unsuccessful

Free text

Release 9 — 3 months, dose 2

2021-08-09

Symptoms: Stuffy nose, cramps, headaches, nausea

Release 11 — 12 months, dose 2

2022-05-10

Symptoms: Gave birth. Frequent cold/flu symptoms and hard time breathing

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Delivery	·	·	✓
SD	Dyspnoea	·	·	✓
SD	Headache	✓	·	✓
SD	Influenza	·	·	✓
SD	Muscle spasms	✓	·	✓
SD	Nasal congestion	✓	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Nausea	✓	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release